✦ LIBER ✦

156 A phase I dose-escalation study with oral LY317615 (L) in combination with capecitabine (C) in advanced cancer patients

✍ Scribed by S. Holden; C. Britten; D. Prager; R. Finn; M. Le; M. Basche; C. O'Bryant; A. Levin; D. Thornton; S. Eckhardt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tesetaxel, a new oral taxane, in combina

✍ Muhammad Wasif Saif; John Sarantopoulos; Amita Patnaik; Anthony W. Tolcher; Chri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

A phase I dose escalation study of conti

✍ Glynne-Jones, R. 📂 Article 📅 2006 🏛 Oxford University Press 🌐 English ⚖ 85 KB

Oral vinorelbine in combination with cap

✍ F Nole; C Catania; G Sanna; E Munzone; L Corsetto; B Longerey; A Saindon; M Bran 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Sunitinib in combination with docetaxel

✍ Francisco Robert; Alan Sandler; Joan H. Schiller; Glenn Liu; Karen Harper; Lev V 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

Erlotinib in combination with capecitabi

✍ Chris Twelves; José M. Trigo; Rob Jones; Flavio De Rosa; Ashok Rakhit; Scott Fet 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 190 KB

A phase I dose escalation study of oral

✍ Welch, John S.; Niu, Haixia; Uy, Geoffrey L.; Westervelt, Peter; Abboud, Camille 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB